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Bone marrow mesenchymal stem cells (MSCs) are a promising cell source for regenerative medicine. However, 
the cellular biology of these cells is not fully understood. The present study characterizes the cyclic ADP-ribose 
(cADPR)-mediated Ca2+ signals in human MSCs and finds that externally applied cADPR can increase the 
frequency of spontaneous intracellular Ca2+ (Ca2+i) oscillations. The increase was abrogated by a specific 
cADPR antagonist or an IP3Rs inhibitor, but not by ryanodine. In addition, the cADPR-induced increase of 
Ca2+i oscillation frequency was prevented by inhibitors of nucleoside transporter or by inhibitors of the TRPM2 
channel. RT-PCR revealed mRNAs for the nucleoside transporters, CNT1/2 and ENT1/3, IP3R1/2/3, and the 
TRPM2 channel, but not those for RyRs and CD38 in human MSCs. Knock-down of the TRPM2 channel by 
specific siRNA abolished the effect of cADPR on the Ca2+i oscillation frequency, and prevented the stimulation 
of proliferation by cADPR. Moreover, cADPR remarkably increased phosphorylated ERK1/2, but not Akt or 
p38 MAPK. However, cADPR had no effect on adipogenesis or osteogenesis in human MSCs. Our results 
indicate that cADPR is a novel regulator of Ca2+i oscillations in human MSCs. It permeates the cell membrane 
through the nucleoside transporters and increases Ca2+ oscillation via activation of the TRPM2 channel, 
resulting in enhanced phosphorylation of ERK1/2 and, thereby, stimulation of hMSC proliferation. This study 
delineates an alternate signaling pathway of cADPR that is distinct from its well established role of serving as a 
Ca2+ messenger for mobilizing the internal Ca2+ stores. Whether cADPR can be used clinically for stimulating 
marrow function in patients with marrow disorders remains further studied. 
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Introduction 
It is well recognized that bone marrow-derived mesenchymal stem cells (MSCs) are present within 
the bone marrow cavity and serve as a reservoir for the continuous renewal of various mesenchymal 
tissues [1-4]. MSCs have recently been moved into the main stream focus by virtue of their plasticity 
and potential applications in various clinical situations [2, 5], such as tissue regeneration and 
haematopoietic stem cell transplantation [1, 6]. In addition, MSCs were widely used for the studies of 
adipogenenic and osteogenenic differentiation [1-4]. However, their cellular biology is not fully 
understood, especially on the regulation of their cellular activities by the cytosolic free calcium ion 
(Ca2+i).  
Ca2+i functions as a highly versatile secondary messenger in virtually all types of eukaryotic cells and 
regulates a wide range of cellular functions, including the regulation of ion channel, gene transcription, 
cell proliferation and differentiation [7]. It is generally recognized Ca2+i are usually mediated by 
inositol trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs). Kawano and colleagues were 
the first to demonstrate that human MSCs exhibit spontaneous Ca2+i oscillations that are initiated by 
autocrine/paracrine ATP via the activation of the IP3R-mediated Ca2+ release, but not RyRs, since no 
RyRs are detected in these cells [8-10]. The physiological role of the Ca2+ oscillation is unknown but 
may be important in regulating cellular proliferation. Indeed, it has been reported in other cells that 
the frequency of Ca2+i sparks determines the gene expression efficiency [11] and controls kinase 
activities [12]. Consistently, a recent study demonstrated that the flow stress-manipulated Ca2+i 
oscillations in human MSCs can indeed regulate proliferation [13]. 
Cyclic adenosine diphosphate ribose (cADPR) has been recognized as a universal Ca2+ mobilizer by 
activating RyRs in many types of cells [14-16]. In addition, cADPR has been reported to mediate Ca2+ 
entry by activating transient receptor potential cation channel melastatin-2 (TRPM2) [14, 17, 18]. It 
plays an important role in the regulation of various cellular behaviors, including insulin secretion [19] 
and cell proliferation [20]. Cyclic ADP-ribose has been attributed as a non-peptide hematopoietic 
growth factor because of its unique role in the stimulation of proliferation of human MSCs [21] and 
its regulation of human hematopoiesis [22-24]. However, the specific mechanism involved is 
unknown. The present study was thus designed to investigate the mechanism of cADPR in regulating 
Ca2+ signaling in human MSCs during proliferation as well as during adipogenic and osteogenic 
differentiation. The results from this study demonstrate an alternate signaling pathway of cADPR that 
is distinct from its well established role of serving as a Ca2+ messenger for mobilizing the internal 
Ca2+ stores in human MSCs, which provide important information that human bone marrow function 
may be regulated by Ca2+ signaling. 
 
 
Materials and methods 
Human MSCs culture 
Human bone marrow MSCs at passage 1 were generously provided by Dr. Darwin J. Prockop, Texas 
A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & 
White. The cells were characterized of positive for surface markers CD44, CD90, CD166, CD105, 
CD29, CD49c, CD147, CD59 and HLA-1, and negative for CD34, CD36, CD45, CD184 and CD106 
(Table S5). These cells have been tested for successful bone and fat differentiation.  The cells were 
cultured at 37°C in 95% air and 5% CO2, in the growth medium, i.e. minimal essential medium alpha 
(α-MEM, Invitrogen, Hong Kong) contained 15% fetus bovine serum (Hyclone, Logan, UT, USA), 2 
mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. When cells grew to 70%~80% 
confluence, they were lifted by 0.25% trypsin and 1 mM ethylene diamine tetraacetic acid (EDTA) in 
phosphate buffered saline (PBS) solution for subculture as described previously  [25].  
Differentiation induction 
Adipogenesis.  Human MSCs were plated into 6-well plates in growth medium and the growth 
medium was changed to adipogenic medium (α-MEM supplemented with 10% FBS, 1 μM 
dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, 50 μM indomethacin and 10 μg/ml insulin) 
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when cells reached confluence. After 3 days induction, the adipogenic medium was replaced by 
maintenance medium (α-MEM supplemented with 10% FBS and 10 μg/ml insulin) and maintained for 
2 days. After 2 or 3 cycles of induction and maintenance, plates were fixed with 4% PBS buffered 
paraformaldehyde solution at 4°C for 1 hour. Followed with washes with PBS to remove 
paraformaldehyde, Oil red O staining solution was added to visualize the oil drops in differentiated 
cells.  
Osteogenesis.   Human MSCs were plated into 6-well plates in growth medium. When cells grew to 
confluence, the growth medium was changed to osteogenic medium (α-MEM supplemented with 10% 
FBS, 100 nM dexamethasone, 10 mM beta-glycerol phosphate and 50 μM L-ascorbic acid-2-
phosphate). The osteogenic medium was replaced every three days. After 21 days induction, plates 
were processed to fixation with PBS buffered 4% paraformaldehyde and staining with Alizarin red S 
for visualization of mineralization [26].  
Reverse transcription and polymerase chain reaction 
The Reverse transcription and polymerase chain reaction (RT-PCR) was performed as previously 
described [25, 27, 28]. Briefly, total RNA extraction was performed with Trizol extraction system. 
RNA pellet was obtained by centrifuge and total RNA was treated with DNase I (GE Healthcare, 
Hong Kong) to remove genomic DNA at 37°C for 30 minutes. RT was performed with the Promega 
Reverse Transcription System in a 20-μ1 reaction mixture. The cDNA product from RT reaction was 
used for PCR amplification of specific gene expression.  
PCR primers were designed with human genes using Primer Premier 5 software (Premier Biosoft 
international, Palo Alto, CA, USA) and synthesized at the Genome Research Center at the University 
of Hong Kong.  The forward and reverse PCR oligonucleotide primers chosen to amplify the cDNA 
are listed in (Table S1-S3). PCR was performed using a Promega PCR system with Taq polymerase 
and accompanying buffers. The thermal cycling conditions were: 94°C for 2 min, 28-30 cycles of 
94°C (45 s), 58°C (45 s), and 72°C (1 min). This was followed by a final extension at 72°C (10 
minutes) to ensure complete product extension. The PCR products were then electrophoresed through 
a 1.5% agarose gel, and the amplified cDNA bands were visualized using ethidium bromide staining 
and imaged using Chemi-Genius Bio Imaging System (Syngene, Cambridge, UK). 
Western blot 
Western blot was performed as previously described [27].  Briefly, Cells at 70~80% confluence were 
lysed with a modified RIPA buffer containing (in mM) 50 Tris-HCl, 150 NaCl, 1 EDTA, 1 PMSF, 1 
sodium orthovanadate, 1 NaF, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1% NP-40, 
0.25% sodium deoxycholate, 0.1% SDS. Protein concentration was determined by Bio-Rad protein 
assay. Cell lysates (50 µg) were mixed with sample buffer and denaturated by heating to 95°C for 5 
minutes. Samples were resolved via SDS-PAGE and transferred to nitrocellulose membranes. 
Membranes were blocked with 5% non-fat milk in TTBS buffer then probed with primary antibodies 
(1:500-1000) at 4°C overnight with agitation. Anti-Akt, anti-p-Akt, anti-ERK1/2, anti-p-ERK1/2, anti-
p38, and anti-p-p38 antibodies were from Millipore (Billerica, MA, USA), while anti-TRPM2 and 
anti-JNK, anti-PPARγ, and anti-osteocalcin antibodies were from Santa Cruz Biotech (Santa Cruz, CA, 
USA). After wash with TTBS, the membranes were incubated with HRP-conjugated goat anti-rabbit 
or donkey anti-goat IgG antibody (Santa Cruz Biotech) at 1:4000 dilutions in TTBS at room 
temperature for one hour. Membranes were washed again with TTBS then processed to develop x-ray 
film using an enhanced chemiluminescence detection system (GE Healthcare, Hong Kong). The 
relative band intensities were measured by quantitative scanning densitometer and image analysis 
software (Bio-1D, version 97.04, Froebel, Wasserburg, Germany).  
Ca2+i measurements 
Ca2+i activity was measured using confocal microscopy scanning technique as described previously 
[29, 30] in human MSCs.  The cells were loaded with 5 μM fluo-3 AM (Biotium, Hayward, CA) in 
the culture medium for 30 min at 37 °C, and then rinsed with PBS to remove extracellular fluo-3 AM 
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and incubated in Tyrode solution at room temperature for 30 min before recording Ca2+i signals. 
Tyrode solution contained (in mM): 140 NaCl, 5.4 KCl, 1 MgCl2, 1.8 CaCl2, 0.33 NaH2PO4, 10 
HEPES and 10 glucose (pH = 7.3). Ca2+i was monitored every 10 s in human MSCs using a confocal 
microscopy (Olympus FV300, Tokyo, Japan) at room temperature (22-23°C).  Fluo-3 was excited at 
488 nm and emission was detected at >505 nm. 
RNA interference 
Short interference RNA (siRNA) molecules targeting different exons of TRPM2 gene were 
synthesized by Ambion Company (Austin, TX). Specific sequences for target genes are shown in 
Table S4. A FAM-labeled sequence which has no known target in the human genome was used as a 
negative control (i.e. control siRNA). The siRNA segments (final concentrations at 50 nM as 
recommended by the supplier) were transfected into human MSCs at 50~60% confluence using 
lipofectamine 2000 (Invitrogen) as described previously [27] or in supplemental experimental 
procedures.  
Cell proliferation assays 
MTT (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay was applied to assess 
the effects of ion channel blockers on cell proliferation [27]. Human MSCs were plated into 96-well 
plate at a density of 5×104 cells per well in 200 µl complete culture medium. After 8 h recovery, the 
culture medium containing ion channel blockers was employed. Following 72 h cADP ribose 
incubation, 20 µl PBS buffered MTT (5 mg/mL) solution was added to each well and the plates were 
incubated at 37°C for additional 4 h. The medium was removed and 100 µl/well dimethyl sulfoxide 
(DMSO) was added to each well to dissolve the purple formazan crystals. The plates were read 
(wavelengths: test, 570; reference, 630 nm) using a µQuant microplate spectrophotometer (Bio-Tek 
instruments Inc.). Results were standardized using control group values. 
[3H]-thymidine incorporation assay was introduced to assess proliferating cell rate [27]. Human MSCs 
were plated into 96-well plate at a density of 5×104 cells per well in 200 µl complete culture medium. 
After 8 h recovery, the culture medium was replaced with a medium containing cADP ribose or 
TRPM2 siRNAs and incubated for 48 h, then 1 µCi (0.037 MBq) 3H-thymidine (GE Healthcare, Hong 
Kong) was added into each well. Following additional 24 h incubation, cells were harvested and 
transferred to a nitrocellulose coated 96-well plate via suction. Nitrocellulose membrane was washed 
with water flow and plate was air dried at 50°C overnight. Liquid scintilla (20 µL per well) was then 
added to each well. Counts per minute (cpm) for each well was read by a TopCount microplate 
scintillation and luminescence counter (PerkinElmer, Waltharn, MA).  
Statistical analysis 
Results are presented as means ± SEM. Paired and/or unpaired Student's t-tests were used as 
appropriate to evaluate the statistical significance of differences between two group means, and 
analysis of variance (ANOVA) was used for multiple groups. Values of P<0.05 were considered to 
indicate statistical significance. 
 
 
Results 
Characterization of the human MSCs 
Human MSCs (passage 4) showed a fibroblast-like appearance at day 3 after sub-culturing and 
became confluence at day 8 (Figure 1).  Figure 1B and 1C display adipogenic and osteogenic 
differentiation in human MSCs at passage 5. The cells could be induced to differentiate efficiently into 
adipocytes (Figure 1B) or osteocytes (Figure 1C), which occurred, however, only after specific 
induction.  RT-PCR (Figure 1D) revealed the expression of lineage specific genes after induction: 
PPARγ and FABP4 for adipocytes, and RUNX2 and osteocalcin for osteocytes [2, 31]. The PCR 
primers used for detection of these specific genes are shown in Table S1. These results indicate that 
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human MSCs we studied here are maintained in the “stem” state before induction.  
We found that the amplitude (1-3 arbitrary units) and frequency (oscillation/2.5-13 min) of the 
spontaneous Ca2+i oscillations were variable from cell to cell (Figure 1E and 1F). The percentage of 
human MSCs exhibiting spontaneous Ca2+i oscillations varied between 86% (110 of 128 cells) in 
passage 2 cells and 78% (100 of 128 cells) in passage 5 cells (Figure 1G). The percentage was further 
reduced to only 12.5% at passage 10 (6 of 128 cells, data not shown), which is most likely related to 
cell senescence in culture [32-34]. Therefore, only human MSCs at passages 2-5 were used in all 
subsequent experiments. 
Spontaneous Ca2+i oscillations in human MSCs were not related to RyRs [8]. Here, we further 
confirmed that the spontaneous Ca2+i oscillations in human MSCs were inhibited by the IP3 inhibitor, 
2-aminoethoxydiphenyl borate, the SERCA inhibitor, cyclopiazonic acid, and the SOC channel 
inhibitor, La3+, but not by ryanodine (Figure S1A-D).  Moreover, RT-PCR also revealed the 
expression of three types of IP3Rs (1/2/3), SERCAs (1/2/3), PMCAs (1/2/3), and NCX (1/3/4) in 
human MSCs, but not RyRs (Figure S1E and S1F).  
Cyclic ADP ribose and Ca2+i oscillations in human MSCs 
Figure 2A shows that the addition of cADPR (50 µM) to the bath solution did not induce Ca2+ changes 
in the cells exhibiting no spontaneous Ca2+i oscillations (n = 16). However, cADPR (10 and 50 µM) 
remarkably enhanced the Ca2+i oscillation frequency in cells with spontaneous Ca2+i oscillations 
(Figure 2B and 2C). 8-Br-cADPR (100 µM), a specific antagonist of cADPR, had no effect on the 
spontaneous Ca2+i oscillations, but prevented the enhancing effect of cADPR on the oscillation 
frequency (Figure 2D). Interestingly, the enhancement of the Ca2+i oscillation frequency by cADPR 
was not affected by 30 µM ryanodine (Figure 2E).  The IP3Rs blocker [8] 2-aminoethoxydiphenyl 
borate (50 µM), which is also a blocker of TRPM2 channels [35], fully suppressed the Ca2+i 
oscillations and antagonized the enhancement on Ca2+i oscillation frequency by cADPR (Figure 2F).  
Therefore, the inhibitory effect could be related at least in part to its action on the TRPM2 channels. 
Indeed, as will be described in detail below, the TRPM2 channel is likely the target of cADPR instead 
of the RyRs.  
The quantitative data for the effects of cADPR on Ca2+i oscillatory frequency are summarized in 
Figure 2G. cADPR at 10 and 50 µM significantly increased Ca2+i oscillation frequency by 69 ± 19% 
and 108 ± 25%, respectively (P<0.05 vs before cADPR). These results suggest that the cADPR-
induced increase of Ca2+i oscillation frequency is dependent on the IP3Rs-mediated pathway, but not 
that mediated by the RyRs. 
Nucleoside transporters are responsible for the transport of cADPR 
Previous studies have demonstrated that concentrative nucleoside transporters (CNTs) and 
equilibrative nucleoside transporters (ENTs) are responsible for the transport of external cADPR into 
human hematopoietic progenitors [24] and HL-60 cells [36]. To determine whether these nucleoside 
transporters are present in human MSCs, the related mRNAs were examined by RT-PCR, which 
showed significant expression of ENT1/ENT2 and CNT1/CNT3 in the cells (Figure 3A). Two other 
components of the cADPR-pathway were also present in human MSCs, the hexameric hemichannel 
connexin 43 (Cx43) and the bone marrow stromal cell antigen-1 (BST-1). Cx43 has been 
demonstrated to mediate the nicotinamide adenine dinucleotide (NAD+) transport and it is known to 
be functionally interacting with the multifunctional ecto-enzymes, CD38 and/or BST-1 (also called 
CD157) in the plasma membrane, both catalyze the synthesis and hydrolysis of cADPR [37]. Indeed, 
BST-1 (CD157) [38, 39], but not CD38, was strongly expressed in human MSCs (Figure 3A). 
Nitrobenzylthioinosine (NBMPR) and dipyridamole were found to block the nucleoside transporters 
ENTs/CNTs [24, 36]. To investigate whether the nucleoside transporters are involved in the 
transportation of cADPR, human MSCs were pre-treated with NBMPR (10 nM) or dipyridamole (100 
nM), and both were effective in blocking cADPR from stimulating the Ca2+i oscillation frequency 
(Figure 3C-3E). 
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The dependence of the cADPR-effect on the TRPM2 channels 
RyR mRNA expression was not found in human MSCs (Figure S1). The negative result is not due to 
the primers we used for RyRs, because all three types of RyR mRNA were detected in human 
neuroblastoma cell line SH-SY5Y using the same primers (Figure S1F), as reported previously [40].  
To investigate whether TRPM2 channels participate in the cADPR-induced increase of Ca2+i 
oscillation frequency, two structurally different inhibitors of the channel, econazole (10 µM) and 
clotrimazole (10 µM) [41], were tested in human MSCs. Both showed no significant effect on the 
spontaneous Ca2+i oscillations, but both effectively prevented the increase of Ca2+i oscillation 
frequency induced by cADPR (Figure 4B and 4C). The quantitative results are summarized in Figure 
4D. RT-PCR (Figure 4E) showed the presence of the mRNA for the full length form of TRPM2, 
TRPM2-L, but not short form, TRPM2-S, which was also confirmed by Western blot analysis (Figure 
4F) for protein expression in human MSCs. These results suggest that the increased Ca2+i oscillation 
frequency by cADPR is most likely mediated by the TRPM2 channels.  
To further investigate the involvement of the TRPM2 channel in mediating the cADPR- regulation of 
the spontaneous Ca2+i oscillations, siRNA molecules (Table S4) targeting human TRPM2 channel 
were transfected into MSCs using the lipofectamine 2000 reagent. The transfection efficiency was 
determined to be >90% at 4 hours after transfection (data not shown). Both the mRNA and protein 
expression of TRPM2 were remarkably reduced by all three of the TRPM2 siRNA molecules, as 
compared to the control siRNA (Figure 5A). TRPM2 protein levels were significantly reduced by 
75% to 89% with the specific siRNAs (Figure 5B and 5C). 
The effect of cADPR on the spontaneous Ca2+i oscillations was examined in human MSCs transfected 
with TRPM2 siRNAs. They were not significantly affected by the transfection of either the control 
siRNA or TRPM2 siRNAs. The percentage (81.3%, 26 out of 32 cells) of cells with Ca2+i oscillations 
after transfection was close to that shown earlier without transfection (Figure 1G). However, the cells 
transfected with TRPM2 siRNA molecules showed no response to cADPR (Figure 5E and 5F), 
whereas in cells transfected with control siRNA, cADPR retained the positive regulatory effect on the 
Ca2+i oscillation frequency (Figure 5D). The quantitative results are summarized in Figure 5G, which 
support the notion that cADPR is a modulator of the spontaneous Ca2+i oscillations in human MSCs, 
and the effect is mediated by the TRPM2 channels.  
 
The effect of cADPR on the proliferation of human MSCs 
Cell proliferation was assessed by the MTT and the 3H-thymidine incorporation assays. Cyclic ADP 
ribose increased cell proliferation in a concentration-dependent manner and significant effects were 
observed at concentrations from 10 to 50 µM (Figure 6A). At 50 μM, the cell proliferation was 
increased by 19 ± 7% as determined by the MTT assay. The effect was completely antagonized by co-
administration of 100 µM 8-Br-cADPR (Figure 6A). Likewise, 3H-thymidine incorporation was 
increased by cADPR in a concentration-dependent way. At 50 µM, DNA synthesis was enhanced by 
32 ± 9% and the effect was fully countered by co-application of 8-Br-cADPR as well (Figure 6B). 
Consistently, the increase in the rate of DNA synthesis by cADPR was not observed in cells 
transfected with the TRPM2 siRNAs (Figure 6C), whereas the effect was still seen in the cells 
transfected with the control siRNA (n = 10, P<0.01). These results indicate that the enhanced cell 
proliferation by cADPR is mediated by the TRPM2 channel.  
The intracellular mechanism of the cADPR-induced cell proliferation 
To determine whether the cADPR-induced increase of proliferation is mediated by MAP kinases, we 
investigated the phosphorylated levels of the extracellular-signal-regulated kinases1/2 (ERK1/2) and 
p38 MAP, and survival kinase Akt.  Figure 7 A shows that a 30-min incubation with cADPR (10 and 
50 µM) increased the phosphorylation level of ERK1/2 (Thr185/Tyr187) in human MSCs, and the 
effect was countered by 8-Br-cADPR (Figure 7A). The effect of cADPR on phosphorylated ERK1/2 
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was time-dependent. The increase of ERK1/2 phosphrylation level was maximal at 60 min, and the 
effect remained significant at 180 min (Figure 7B). However, the increase of phosphorylated ERK1/2 
by cADPR was remarkably reduced in the cells transfected with molecule A of TRPM2 siRNAs. 
Cyclic ADPR (50 µM, 60 min incubation) only induced a slight increase of phosphorylated level of 
ERK1/2 in TRPM2 siRNA (n=3, P=NS) (Figure 7C).   
On the other hand, the phosphorylation levels of Akt (Thr308/Ser473), p38 MAPK (Thr180/Tyr182), 
and JNK (Thr183/Tyr185) were not significantly affected by cADPR (10 or 50 µM) in human MSCs 
(Figure 7E-7G). These results showed the specificity of the signaling cascade activated by cADPR in 
human MSCs, linking via ERK1/2, but not Akt, p38 MAPK or JNK. Consistently, it is well known 
that ERK1/2 is involved in promoting cell proliferation [42]. 
The lack of effect of cADPR on adipogenesis and osteogenesis in human MSCs 
The effect of cADPR on adipogenesis was determined in human MSCs by application of cADPR (50 
µM) in the adipogenic induction medium. Three cycles (3 days/cycle) of induction were employed 
and Oil red O staining performed at each cycle showed an increase of adipogenesis with each cycle, 
but cADPR had no effect on adipogenesis (Figure S2A), and No difference of PPARγ expression was 
observed in the differentiated cells treated with and without cADPR application (Figure S2B). The 
spontaneous Ca2+i oscillations disappeared as differentiation progressed, and cADPR (50 µM) could 
not induce Ca2+i changes before, during and after adipogenesis (Figure S2C).  
The effect of cADPR on osteogenesis was determined in human MSCs by application of cADPR (50 
µM) in the osteogenic induction medium for 21 days, with fresh medium replacement every 3 days. 
Mineralization staining with Alizarin red S displayed the increased osteogenesis with prolonged 
induction time and cADPR again had no significant effect on osteogenesis as compared to the control 
group (Figure S3A), and no difference of osteocalcin protein expression was observed in the 
differentiated cells treated with and without cADPR application (Figure S3B).  Similar to that 
observed in adipogenesis, the spontaneous Ca2+i oscillations disappeared after osteogenesis, and 
cADPR (50 µM) could not induce Ca2+i changes during osteogenesis either (Figure S3B).  
 
 
Discussion 
Cyclic ADP ribose is a well-known endogenous Ca2+ mobilizing cyclic nucleotide that targets the 
intracellular Ca2+ stores in the endoplasmic reticulum in many cell types and species covering 
protozoa, plants and animals, including humans [15, 17]. It is formed by ADP-ribosyl cyclases (CD38 
and/or BST-1) from NAD+. Cyclic ADP-ribose has been established as a second messenger for Ca2+ 
signaling in an equally wide range of cell types [14, 15, 17]. Most unexpectedly, in addition to being 
an intracellular second messenger, cADPR has recently been proposed to function as a non-peptide 
hematopoietic growth factor stimulating the expansion of human hematopoietic progenitors in an 
autocrine/paracrine fashion [21, 24, 43]. It is proposed that cells can release cytoplasmic NAD+ via 
the connexin 43 hemi-channels, and is converted extracellularly by the ecto- CD38 and/or BST-1 to 
cADPR. The latter is then transported back into the progenitors by the nucleoside transporters to 
perform its Ca2+ signaling function intracellularly [44]. The results presented in this study are fully 
consistent with this novel scheme. Hence, we show that external cADPR can increase the frequency 
of spontaneous Ca2+i oscillations in human MSCs and stimulate their proliferation. All the components 
of the autocrine/paracrine-pathway, Cx34, BST-1, CNTs and ENTs are well expressed in the cells 
(Figure 3A) and blocking the transport function of the nucleoside transporters indeed inhibits the 
effects of cADPR.  
The intracellular target for cADPR is generally believed to be the ryanodine receptors (RyRs) [14, 15, 
17]. However, recent studies have demonstrated that TRPM2 channel is also a target of cADPR [18, 
45, 46]. In the present study, we did not find functional or molecular evidence for the presence of the 
RyRs in human MSCs (Figure S1). This is consistent with a previous report [8] and the idea that RyRs 
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are expressed mainly in differentiated cells, but not in stem cells [47-49].  
Our results strongly support the notion that the TRPM2 channel [41] is responsible for mediating the 
cADPR-induced increase of Ca2+i oscillation frequency and cell proliferation in human MSCs. First, 
both the mRNA and protein of TRPM2 are strongly expressed in human MSCs. Second, blocking the 
TRPM2 channels pharmacologically using clotrimazole or enconazole or knocking down the channel 
expression specifically using siRNAs, all inhibit the effects of cADPR (Figure 4).  Although the effect 
of cADPR on IP3Rs is likely involved, the efficacy would be weaker than that on TRPM2 channels.    
The TRPM2 channel was initially found to be functionally activated by ADP-ribose by gating at 
NUDT9-H domain of the channel and acting as an intrinsic deactivation mechanism through its 
breakdown [50]. Further studies show that cADPR can synergize the action of ADP-ribose on TRPM2 
channel activation [18]. In Junket lymphocytes, cADPR can actually activate the TRPM2 channel 
directly and the effect is antagonized by 8-Br-cADPR, but not by the ADP-ribose antagonist, AMP. In 
addition, 8-Br-cADPR does not counter the activation of TRPM2 channel by ADP-ribose, indicating 
that cADPR and ADP-ribose have distinct binding sites on the TRPM2 channel [46]. In pancreatic 
islets, cADPR evokes Ca2+ entry and insulin release, and the effect is significantly diminished by the 
application of specific siRNAs targeting to the TRPM2 channels [45]. Consistently, we show that 8-
Br-cADPR inhibits the cADPR effects in a manner similar to that exerted by either the TRPM2 
antagonists or the siRNA knock-down, indicating TRPM2 is the specific target of cADPR in human 
MSCs.  
We demonstrate in this study that the functional consequence of the increase in Ca2+ oscillations 
induced by cADPR is the stimulation of cell proliferation. Thus, blocking the enhancing effect of 
cADPR on Ca2+ oscillation using either 8-Br-cADPR or TRPM2 siRNA correspondingly inhibits the 
stimulation of proliferation (Figure 6), showing the two are causally correlated. This is consistent with 
previous studies showing that the frequency of Ca2+i sparks can determine the efficiency of gene 
expression in T-lymphocytes [11]. Likewise, in human MSCs the flow stress-manipulated Ca2+i 
oscillations have been reported to regulate proliferation as well [13]. The resultant effect of the 
increased Ca2+ oscillations appears to be the simulation of the activities of signaling kinases, as shown 
in HeLa cells [12]. Indeed, we find that cADPR-promoted proliferation of human MSCs is mediated 
by enhancing phosphorylation of ERK1/2, but not Akt or P38 MAPK (Figure 7). ERK1/2 is involved 
in promoting cell proliferation [42]. This is consistent with the previous observation that the fluid flow 
stress-manipulated Ca2+i oscillations increased cell proliferation is also related to increased 
phosphorylation of ERK1/2 in human MSCs [13].   
In contrast to the positive correlation between enhancement of Ca2+ signaling and cell proliferation, 
we observe that cell differentiation, both adipogenesis and osteogenesis, leads to cessation of Ca2+ 
oscillation. Consistently, cADPR, a Ca2+ messenger, also shows no effect on differentiation (Figure S2 
and Figure S3). A similar dichotomic relationship between the cADPR-dependent Ca2+ signaling and 
cell proliferation verses differentiation is also observed in PC12 cells. Thus, activation of the cADPR-
pathway is shown to simulate proliferation of PC12 cells, while blockage of the pathway accelerates 
their neuronal differentiation [51].   
It is well known that the characteristics is not identical in human MSCs defined by surface markers 
and cells isolated from different sources and/or different individuals [21, 24, 52-54], and therefore an 
intrinsic limitation in using the isolated human MSCs should be noted. There are at least two subset 
populations of human MSCs (e.g. surface marker CD106+ or CD106-) demonstrated by different 
laboratories [21, 24, 52-54]. The expression of CD106 was found to be restricted to the MSCA-1+ and 
CD56− MSCs subset [52]. The molecular characteristics may be different in these two subset human 
MSCs. For example, Scarfi and colleagues have demonstrated that the MSCs they used express 
surface marker CD106 in 34-78% cells and show significant differences from those (only 0.8% MSCs 
expressing CD106) we used in this study (Table S5). In particular, mRNAs for CD38, RyR1 and 
RyR3 are detected, and no spontaneous Ca2+ oscillations are observed in their MSCs (Scarfi et al., 
2008). Most importantly, however, despite these differences, both subsets MSCs are responsive to 
cADPR and show enhanced Ca2+ signaling that leads to stimulation of cell proliferation [21], 
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providing a strong evidence that the cADPR-pathway is of fundamental importance in regulation cell 
proliferation of human MSCs, independent of the population difference.     
It is well recognized that human MSCs are precursors of hemopoietic stroma which plays an essential 
role in the bone marrow microenvironment by providing hemopoietic progenitors with soluble factors 
essential to their proliferation and differentiation and by preventing lymphocyte activation [1-4]. 
MSCs regulate hemopoiesis through the production of both growth-promoting and cytotoxic factors 
[55, 56] to produce biochemical signals that are produced by MSCs and active on hemopoietic stem 
cells, which include cADPR [21, 24, 43]. Cyclic ADPR produced by MSCs is clearly a growth-
promoter of human MSCs (Figure 6) [21] and hemopoietic progenitors [24, 43].  
In the present study, we limited the cell passages 2 to 5, because it has been reported that human 
MSCs entered senescence and lose multilineage differentiation potency during in vitro passaging [32-
34], and biological features and gene expression profile in MSCs could vary between early passages 
and late passages [57]. The cells used in the present study maintained ’stem’ capability, which is 
reflected in the differentiation experiments (Figure 1, Figure S2 & Figure S3).    
Collectively, the present study demonstrates that application of cADPR in bath medium positively 
regulates the frequency of spontaneous Ca2+i oscillations and cell proliferation in human MSCs. These 
effects are mediated by the nuclear transporters CNTs and/or ENTs, TRPM2 channel, and the 
activation of the MAP kinases ERK1/2. Therefore, cADPR is a cell cycling promoter of MSCs by 
positive regulation of Ca2+i oscillations. The results suggest that cADPR likely play an essential role 
in maintaining in situ normal function of bone marrow microenvironment in humans. Whether 
cADPR can be used clinically for stimulating bone marrow function in patients with marrow disorders 
remains further studied. 
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Figure 1. Characteristics of human MSCs.  (A) Cells in culture on day 3 (left) and day 8 (right) 
from subculture from passage 4. (B) Adipogenic differentiation of human MSCs (passage 5) in 
control (left) and adipogenic supplement (right). Cells were stained with Oil red O. (C) 
Osteogenic differentiation of human MSCs (passage 5) in control (left) and osteogenic 
supplement (right). Cells were stained with Alizarin red S. (D) RT-PCR revealed the lineage 
specific genes expression in cells from controls and adipogenic and osteogenic differentiation 
cultures. PPARγ, peroxisome proliferator-activated receptor gamma; FABP4, fatty acid binding 
protein 4; RUNX2, runt related transcription factor 2. (E) ‘Pseudo’-color images show changes 
in fluorescence intensity (i.e. Ca2+i) in the cell at time points a, b, c, d, as indicated in F. (F) 
Spontaneous Ca2+i oscillations observed in a representative cell from passage 3. The pseudo-ratio 
δF/F0: δF/F0 = (F−Fbase)/Fbase was applied to express Ca2+i level, where F is the measured 
fluorescence intensity of Fluo-3, Fbase is the lowest level of fluorescence intensity in the cell.  (G) 
Incidence of spontaneous Ca2+i oscillations in human MSCs from passages 2 and 5. 
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Figure 2.  Effects of cADPR on spontaneous Ca2+i oscillations. (A) Cyclic ADP ribose did not 
initiate Ca2+i transient or Ca2+i oscillations in the cell without spontaneous Ca2+i oscillations. (B 
and C) Cyclic ADP ribose increased frequency of Ca2+i oscillations at 10 and 50 µM. (D) 8-Br-
cADPR prevented the effect of cADPR on Ca2+i oscillations. (E) Ryanodine (30 µM) did not 
antagonize the cADPR effect. (F) IP3Rs blocker 2-APB (50 µM) blocked Ca2+i oscillations and 
prevented the cADPR effect. (G) Mean values of Ca2+i oscillation frequencies in the absence or 
presence of cADPR with under conditions of the effects of 10 µM (n=20), 50 µM (n=36), 100 
µM 8-Br-cADPR plus 50 µM cADPR (n=23), and 30 µM ryanodine plus 50 µM cADPR (n=21) 
on frequency of Ca2+i oscillations. *P<0.05 vs before cADPR, #P<0.05 vs 10 µM cADPR.   
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Figure 3. Nucleoside transporters and cADPR transportation. (A) RT-PCR detected 
significant gene expression for CNT1, CNT3, ENT1, ENT2, BST-1 and Cx43. No significant 
CD38 gene expression was detected in human MSCs. CNT: concentrative nucleoside transporter; 
ENT: equilibrative nucleoside transporter; BST-1: bone marrow stroma antigen-1; Cx43: 
connexin 43. (B) Spontaneous Ca2+i oscillations in a representative cell. (C) cADPR had no 
significant effect on Ca2+i oscillations in the cell pretreated with 10 nM NBMPR 
(nitrobenzylthioinosine). Similar results were obtained in a total of 10 cells. (D) The nucleoside 
transporter inhibitor dypyridamole (100 nM) prevented cADPR effect. (E) Mean values for the 
effects of 50 µM cADPR (n=36), 10 nM NBMPR plus 50 µM cADPR (n=10) and 100 nM 
dipyridamole plus 50 µM cADPR (n=11) on the frequencies of Ca2+i oscillations. *P<0.05 vs 
before cADPR.  
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Figure 4. TRPM2 channel and cADPR in human MSCs.  (A) Cyclic ADP ribose increased 
frequency of Ca2+i oscillations in a representative cell. (B) Cyclic ADP ribose had no significant 
effect on Ca2+i oscillations in the cell pretreated with the TRMP2 channel inhibitor clotrimazole. 
(C) Econazole prevented cADPR effect on Ca2+i oscillations. (D) Mean values for the effects of 
50 µM cADPR (n=36), 10 µM clotrimazole plus 50 µM cADPR (n=23), and 10 µM econazole 
plus 50 µM cADPR (n=26) on frequency of Ca2+i oscillations. *P<0.05 vs before cADPR.  (E) 
RT-PCR revealed the expression of full length isoform of TRPM2 (TRPM2-L) gene. (F) Western 
blot analysis showed TRPM2 channel protein in human MSCs from passages 2, 5 and 8. 
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Figure 5. Knockdown of TRPM2 channel and cADPR effect on Ca2+i oscillations. (A) RT-
PCR images showed the reduced gene expression of TRPM2 channel after transfection with the 
specific siRNA A, B, and C. (B) Western blot analysis showed decreased TRPM2 channel 
protein by the specific siRNA A, B, and C. (C) The mean relative values of TRPM2 channel 
protein in cells transfected with control siRNA or with the specific siRNAs. n=3, **P<0.01 vs 
control siRNA. (D) Cyclic ADP ribose increased the frequency of Ca2+i oscillations in cells 
transfected with control siRNA.  (E and F) Cyclic ADP ribose had no effect on Ca2+i oscillations 
in cells transfected with TRPM2 siRNA A or B. (G) Cyclic ADP ribose increased the frequency 
of Ca2+i oscillations in cells transfected with control siRNA. G: Mean values for the effects of 50 
µM cADPR on frequency of Ca2+i oscillations in cells transfected with TRMP2 siRNA A (n=26) 
and B (n=27), and control siRNA (n=25). *P<0.05 vs before cADPR. 
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Figure 6. Effect of cADPR on cell proliferation in human MSCs. (A) Cyclic ADP ribose 
increased cell proliferation (assessed by MTT assay) in a concentration-dependent manner. The 
effect was antagonized by 100 µM 8-Br-cADPR. n=10, *P<0.05, **P<0.01 vs 0 µM cADPR. (B) 
Cyclic ADP ribose increased 3H-thymidine incorporation in a concentration-dependent manner, 
and the effect was antagonized by 100 µM 8-Br-cADPR. n =10, *P<0.05, **P<0.01 vs 0 µM 
cADPR. (C) Cyclic ADP ribose did not increase 3H-thymidine incorporation in cells transfected 
with TRMP2 siRNA A or B. n=10, *P<0.05 vs without cADPR application. 
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Figure 7. Cyclic ADP ribose and proliferation-related kinases. (A) ERK1/2 phosphorylation 
at Thr185/Tyr187 was enhanced in the presence of cADPR (10 and 50 µM) for 60 min and 8-Br-
cADPR (100 µM) reduced the effect (upper panels). Mean values (lower panel) for ratio of p-
ERK1/2:total ERK1/2 (n=3, *P<0.05, **P<0.01 vs 0 µM cADPR). (B) Time-dependent effect of 
cADPR on ERK1/2 phosphorylation and mean values for ratio of p-ERK1/2:total ERK1/2 in the 
presence of cADPR for 30, 60, 120, and 180 min (n=3, **P<0.01 vs 0 µM cADPR). (C) ERK1/2 
phosphorylation and mean values for ratio of p-ERK1/2:total ERK1/2 in the presence of cADPR 
in the cells transfected with control siRNA or TRPM2 siRNA for 72 h (n=3, **P<0.01 vs 0 µM 
cADPR).    (D) Akt1 phosphorylation at Thr308 and Ser473 was not affected by cADPR (10 and 
50 µM for 60 min). (E) Mean values for ratio of p-Akt(308):total Akt (n=3) and p-Akt(473):total 
AKT (n=3). (F) p38 MAPK phosphorylation levels at Thr180/Tyr182 were not changed when 
incubated with cADPR (10 and 50 µM) for 60 min (n=3).  (G) JNK phosphorylation levels at 
Thr183/Tyr185 were not changed when incubated with cADPR (10 and 50 µM) for 60 min (n=3).   
 
 
